182 related articles for article (PubMed ID: 23044365)
21. Borderline ovarian tumours: clinical analysis of 38 cases.
Behtash N; Modares M; Abolhasani M; Ghaemmaghami F; Mousavi M; Yarandi F; Hanjani P
J Obstet Gynaecol; 2004 Feb; 24(2):157-60. PubMed ID: 14766453
[TBL] [Abstract][Full Text] [Related]
22. Behavior of serous borderline ovarian tumors with and without micropapillary patterns: results of a French multicenter study.
Fauvet R; Demblocque E; Morice P; Querleu D; Daraï E
Ann Surg Oncol; 2012 Mar; 19(3):941-7. PubMed ID: 21879267
[TBL] [Abstract][Full Text] [Related]
23. Krukenberg tumor of ovary with features of mucinous cystadenocarcinoma.
Thomas S; Chandi SM
Indian J Cancer; 1999; 36(2-4):205-7. PubMed ID: 10921229
[TBL] [Abstract][Full Text] [Related]
24. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells?
Sadeghi S; Ylagan LR
Diagn Cytopathol; 2004 May; 30(5):313-9. PubMed ID: 15108228
[TBL] [Abstract][Full Text] [Related]
25. [Accuracy of frozen section in diagnosis of ovarian tumors].
Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):601-3, 635. PubMed ID: 8112130
[TBL] [Abstract][Full Text] [Related]
26. [Morphometrical and immunohistochemical criteria of prognosis in patients with serous and mucinous ovarian carcinoma].
Kolosov AE; Novichkov EV
Arkh Patol; 2003; 65(5):29-32. PubMed ID: 14664145
[TBL] [Abstract][Full Text] [Related]
27. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
28. [Elevated Ca 19.9 tumor marker without evidence of malignancy].
Gonzalez Bosquet E
Medicina (B Aires); 2007; 67(3):285-6. PubMed ID: 17628919
[TBL] [Abstract][Full Text] [Related]
29. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
30. Diversity in size and signal intensity in multilocular cystic ovarian masses: new parameters for distinguishing metastatic from primary mucinous ovarian neoplasms.
Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
J Magn Reson Imaging; 2013 Oct; 38(4):794-801. PubMed ID: 23440747
[TBL] [Abstract][Full Text] [Related]
31. Serous and mucinous borderline (low malignant potential) tumors of the ovary.
Acs G
Am J Clin Pathol; 2005 Jun; 123 Suppl():S13-57. PubMed ID: 16100867
[TBL] [Abstract][Full Text] [Related]
32. Struma ovarii: MRI findings.
Matsuki M; Kaji Y; Matsuo M; Kobashi Y
Br J Radiol; 2000 Jan; 73(865):87-90. PubMed ID: 10721328
[TBL] [Abstract][Full Text] [Related]
33. MRI of endometriotic cysts in association with ovarian carcinoma.
Tanaka YO; Okada S; Yagi T; Satoh T; Oki A; Tsunoda H; Yoshikawa H
AJR Am J Roentgenol; 2010 Feb; 194(2):355-61. PubMed ID: 20093596
[TBL] [Abstract][Full Text] [Related]
34. Human telomerase reverse transcriptase (hTERT) expression in borderline ovarian tumors: an immunohistochemical study.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2009 Mar; 92(3):308-14. PubMed ID: 19301721
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathologic features of 234 cases with borderline ovarian tumors].
Ren J; Lou JY; Liu H; Wang P; Zhang JW; Yang KX; Wang HJ; Qie MR; Peng ZL
Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):116-20. PubMed ID: 19570422
[TBL] [Abstract][Full Text] [Related]
36. Malignant or borderline mucinous cystic neoplasms have a larger number of loculi than mucinous cystadenoma: a retrospective study with MR.
Okamoto Y; Tanaka YO; Tsunoda H; Yoshikawa H; Minami M
J Magn Reson Imaging; 2007 Jul; 26(1):94-9. PubMed ID: 17659568
[TBL] [Abstract][Full Text] [Related]
37. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
38. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
39. [Study on expression of proliferating cell nuclear antigen (PCNA) in ovarian cancer].
Terauchi F; Ueno R; Tanabe K; Ogura H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Nov; 48(11):1058-62. PubMed ID: 8940694
[TBL] [Abstract][Full Text] [Related]
40. Fibrous tumours of the ovary: aetiologies and MRI features.
Montoriol PF; Mons A; Da Ines D; Bourdel N; Tixier L; Garcier JM
Clin Radiol; 2013 Dec; 68(12):1276-83. PubMed ID: 23937826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]